About US
Contact us
-
SFDA：Diagram of reexamination procedure of administrative protection for pharmaceuticalsSOURCE:SFDA2009/12/23
-
Dow Adhesives and Functional Polymers Announces Global Price IncreasesPHILADELPHIA--(BUSINESS WIRE)--Dow Adhesives and Functional Polymers will implement a price increase for all acrylic and acrylic-based products sold to the pressure sensitive, construction, textile no2009/12/22
-
BASF launches new decorative paints brand for ChinaShanghai, China – December 18, 2009 – BASF Coatings, the coatings division of BASF, today announced the launch of NORBINTM, its first decorative paints brand for the China market in response to it2009/12/22
-
Price Rise for DEGALAN®, DEGACRYL®, DEGADUR®, DEGAROUTE®, DEGAPLAST®, DEGADECK®, DEGAMENT®, ROHAGIT® and PLEX®Evonik Industries’ Coatings & Additives Business Unit has announced it will raise prices for DEGALAN®, DEGACRYL®, DEGADUR®, DEGAROUTE®, DEGAPLAST®, DEGADECK®, DEGAMENT®2009/12/22
-
sfda:Diagram of revoke procedure of administrative protection for pharmaceuticals2009/12/21
-
sfda:Diagram of the examination and approval procedure of administrative protection for Pharmaceuticals2009/12/21
-
Researchers from BASF and KIT jointly develop integrated processes to produce nanostructured functional materialsThe Karlsruhe Institute of Technology (KIT) and BASF SE have founded “IP3” (innovative products, intelligent particles, integrated processes), a joint laboratory for process technology in Karlsruhe. J2009/12/21
-
Application Form for Importing New Strain2009/12/18
-
Evonik:One Hundred Fifty Million Euros Invested in Solar Energy and Electronics Markets of the Futureovember 24, 2009 Construction of an integrated production plant for monosilane and AEROSIL® in Japan Entry into thin-layer photovoltaics First step with monosilanes taken in the highly attr2009/12/18
-
Clavis Pharma Reports Positive Phase II Clinical Data for ElacytarabineClavis Pharma ASA recently announced that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AM2009/12/18